awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33576363-74BDAE1A-E125-4A17-B7A8-F8AB4C29EB4A
Q33576363-74BDAE1A-E125-4A17-B7A8-F8AB4C29EB4A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33576363-74BDAE1A-E125-4A17-B7A8-F8AB4C29EB4A
Emerging therapies for acute myeloid leukemia.
P2860
Q33576363-74BDAE1A-E125-4A17-B7A8-F8AB4C29EB4A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33576363-74BDAE1A-E125-4A17-B7A8-F8AB4C29EB4A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
637cf83d4957be5d20bb834c1138c53911df9ff8
P2860
Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML.